In our upcoming Q4 DTx advisory board session, HealthXL and our esteemed advisory board members will come together to discuss important updates and strategic decisions for the HealthXL DTx community. We will review progress made during Q3, including updates on current initiatives, and seek input and feedback from the advisory board members.
This session will also provide an opportunity for the group to discuss the current economic climate and its potential impact on the DTx industry. The insights shared during this discussion will be critical in shaping the pathway of upcoming events and discussions in Q4.
We highly value the input and feedback of our advisory board members, which is instrumental in guiding our decision-making and ensuring that we stay abreast of the latest developments and challenges in the DTx industry.
